This is the first randomized controlled trial investigating the efficacy and safety of low-dose prolonged methylprednisolone administration in early ARDS. This study tested a pathophysiologic ...
Background/aims We evaluated longitudinal autoantibody changes after intravenous methylprednisolone (IVMP), compared them with those in untreated patients and identified prognostic factors for ...
The graft versus host disease market is experiencing significant growth, driven by the ongoing adoption of branded therapies such as JAKAFI, IMBRUVICA, ORENCIA, and REZUROCK compared to off-label ...
All patients were younger than 10 years of age. The patients received either high-dose treatments (0.5–1.0 mg subconjunctival depot, dexamethasone 4 mg/mL, or methylprednisolone acetate 40mg/mL,, and ...